02269.HK
WuXi Biologics (Cayman) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 49.18
−3.00%Next report
Analyst consensus
- Next report date
- Mar 23, 2027
- EPS estimate
- HKD 0.84
- Revenue estimate
- HKD 16.0B
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- HKD 0.67
- EPS estimate
- HKD 0.52
- Revenue actual
- HKD 13.6B
- Revenue estimate
- HKD 13.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +28.9%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 23, 2027